Answers are grounded in this paper and cite their sources.
(−)-Germacrene D is a bioactive sesquiterpene with demonstrated insect-repellent and behavioral regulatory activities. Here we report an integrated three-pronged strategy combining distal enzyme engineering, intrinsically disordered peptide (IDP) fusion, and pathway-level regulation to boost (−)-germacrene D production in the terpene-tolerant chassis Serratia marcescens HBQA7. A semi-rational distal mutagenesis pipeline—integrating spatial shell stratification, ConSurf conservation filtering, and Pythia folding ΔΔG screening—identified 58 candidate sites from 411 distal residues and yielded the double mutant XsGDS V52E/C183V with 2.5 g L −1 of (−)-germacrene D. N-terminal fusion of the NEXT IDP tag, selected from eight candidates, increased (−)-germacrene D production to 5.3 g L −1 without increasing the intrinsic catalytic efficiency of GDS. Promoter-based regulation of mvk using a stationary-phase promoter library further increased the titer to 6.3 g L −1 . Fed-batch fermentation at the 5 L scale ultimately delivered 46.1 g L −1 of (−)-germacrene D with a glucose conversion yield of 16.2% (w/w)—the highest germacrene-type sesquiterpene titer reported to date.
No takes yet. Share an insight, caveat, or question.
Xia et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: